Literature DB >> 22378662

Clinical and polygraphic improvement of breathing abnormalities after valproate in a case of Pitt-Hopkins syndrome.

Ilenia Maini1, Gaetano Cantalupo, Emanuela Claudia Turco, Fernando De Paolis, Cinzia Magnani, Liborio Parrino, Mario Giovanni Terzano, Francesco Pisani.   

Abstract

Pitt-Hopkins syndrome is a rare genetic form of severe psychomotor delay, caused by mutations in transcription cell factor-4 gene and characterized by distinctive dysmorphic features and abnormal breathing pattern. The current report describes the polygraphic features of the syndrome's typical breathing pattern in a patient both in wakefulness and in sleep. The control of these breathing alterations is important to prevent the neurological sequelae linked to chronic cerebral hypoxemia in early ages. No data are available on effective treatment options for breathing abnormalities of Pitt-Hopkins syndrome. The authors polygraphically documented a reduction of apneic and hypopneic phenomena, with a significant improvement in saturation values, after the introduction of sodium valproate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378662     DOI: 10.1177/0883073811435917

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

Review 1.  Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.

Authors:  Kimberly Goodspeed; Cassandra Newsom; Mary Ann Morris; Craig Powell; Patricia Evans; Sailaja Golla
Journal:  J Child Neurol       Date:  2018-01-10       Impact factor: 1.987

2.  A Case Report of Topiramate for Severe Breath Holding Spells in a Teenage Boy with Pitt-Hopkins Syndrome.

Authors:  Megan Bone; Kimberly Goodspeed
Journal:  Child Neurol Open       Date:  2022-04-13

3.  Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function.

Authors:  Andrew J Kennedy; Elizabeth J Rahn; Brynna S Paulukaitis; Katherine E Savell; Holly B Kordasiewicz; Jing Wang; John W Lewis; Jessica Posey; Sarah K Strange; Mikael C Guzman-Karlsson; Scott E Phillips; Kyle Decker; S Timothy Motley; Eric E Swayze; David J Ecker; Todd P Michael; Jeremy J Day; J David Sweatt
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

4.  Molecular Mechanisms of Transcription Factor 4 in Pitt Hopkins Syndrome.

Authors:  Matthew D Rannals; Brady J Maher
Journal:  Curr Genet Med Rep       Date:  2017-02-11

Review 5.  Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription.

Authors:  J David Sweatt
Journal:  Exp Mol Med       Date:  2013-05-03       Impact factor: 8.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.